Naltrexone (drug)
13976A (R01 DA016834)
Phase 2 small_molecule completed
Quick answer
Naltrexone (drug) for Smoking is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Smoking
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed